UL Solutions Operating Cash Flow increased by 52.1% to $219.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 42.2%, from $154.00M to $219.00M. Over 3 years (FY 2022 to FY 2025), Operating Cash Flow shows an upward trend with a 17.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $93.00M | $93.00M | $93.00M | $93.00M | $161.00M | $59.00M | $121.00M | $126.00M | $141.00M | $103.00M | $150.00M | $130.00M | $154.00M | $147.00M | $155.00M | $144.00M | $219.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +73.1% | -63.4% | +105.1% | +4.1% | +11.9% | -27.0% | +45.6% | -13.3% | +18.5% | -4.5% | +5.4% | -7.1% | +52.1% |
| YoY Change | — | — | — | — | +73.1% | -36.6% | +30.1% | +35.5% | -12.4% | +74.6% | +24.0% | +3.2% | +9.2% | +42.7% | +3.3% | +10.8% | +42.2% |